Radiographic findings associated with surfactant treatment.

Area of Science:

• Neonatal Medicine
• Pulmonology
• Radiology

Background:

• Respiratory distress syndrome (RDS) is a common condition in premature infants.
• Mechanical ventilation is often required for RDS, increasing the risk of lung injury.
• Surfactant replacement therapy aims to improve lung function and reduce complications.

Purpose of the Study:

• To evaluate the effect of modified bovine surfactant extract (Surfactant-TA) on chest radiograph (CXR) findings in infants with RDS.
• To assess the incidence of specific radiological complications following surfactant treatment.

Main Methods:

• A randomized controlled trial involving 35 infants (birthweight 1000-1500 gm) with RDS requiring mechanical ventilation.
• Infants received either saline (control) or Surfactant-TA intratracheally.
• Chest radiographs were analyzed before and 24 hours after treatment using a scoring system and noting specific complications.

Main Results:

• No significant differences in overall CXR scores were observed between the surfactant and control groups.
• A higher incidence of pneumothorax and pulmonary interstitial emphysema was noted in the control group.
• Surfactant-treated infants showed an increased incidence of asymmetric parenchymal involvement.

Conclusions:

• Surfactant-TA did not significantly improve radiographic lung inflation or density in this cohort.
• Findings suggest a potential protective role of surfactant against barotrauma (pneumothorax, pulmonary interstitial emphysema).
• The increased asymmetric involvement in surfactant-treated infants highlights the need to investigate potential drug maldistribution.